HomeCare for Dementia

CG
ST
Overseen BySarah Tomaszewski-Farias, PhD
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: HiDO Technologies
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will evaluate whether the HomeCare medication management system can improve medication adherence and related outcomes for adults age 65 and older living with dementia, Alzheimer's disease, or related dementias.

HomeCare is an internet-connected medication management device that can automate medication dispensing, monitor medication use, and provide alerts to caregivers. The system is integrated with a Pharmacy Distribution System designed to track medications from pharmacy delivery through use in the home.

A total of 120 participants with dementia will be randomly assigned to one of two groups. One group will use the HomeCare system, while the other group will continue using standard medication management methods, such as pill bottles or blister packs. Participants will be followed for 12 months. The main outcome is medication adherence. The study will also examine hospitalizations and emergency room visits, cognitive function, caregiver burden, quality of life, satisfaction, and changes in medication-management behavior. Caregivers will also participate in surveys and study assessments. The study is intended to determine whether HomeCare can improve medication management and support both people living with dementia and their caregivers.

Are You a Good Fit for This Trial?

This trial is for adults age 65 or older who have dementia, Alzheimer's disease, or related memory problems and live at home. Participants must be taking regular medications and have a caregiver to help with their care.

Inclusion Criteria

Access to a smartphone, tablet, or computer with internet connectivity
Able to communicate in either English or Spanish
I can give consent or have someone legally able to consent for me.
See 2 more

Exclusion Criteria

Significant comorbidities or medical conditions that could interfere with participation or severe cognitive function
History of severe psychiatric illness or substance abuse disorder
Recent participation in other clinical trials targeting cognition or dementia
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • HomeCare

Trial Overview

The study compares the HomeCare medication management system—a smart device that dispenses medicine and alerts caregivers—to usual ways of managing medicines like pill bottles. Participants are randomly assigned to either group for 12 months.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: HomeCare System (Intervention Group)Experimental Treatment1 Intervention
Group II: Standard of Care (Control Group)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

HiDO Technologies

Lead Sponsor

Trials
2
Recruited
80+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

University of California, Davis

Collaborator

Trials
958
Recruited
4,816,000+